Petros Pharmaceuticals Inc (NASDAQ:PTPI) has a beta value of 1.89 and has seen 106.55 million shares traded in the last trading session. The company, currently valued at $3.32M, closed the last trade at $0.29 per share which meant it gained $0.04 on the day or 18.38% during that session. The PTPI stock price is -682.76% off its 52-week high price of $2.27 and 24.14% above the 52-week low of $0.22. If we look at the company’s 10-day average daily trading volume, we find that it stood at 11.16 million shares traded. The 3-month trading volume is 2.08 million shares.
Petros Pharmaceuticals Inc (NASDAQ:PTPI) trade information
Sporting 18.38% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the PTPI stock price touched $0.29 or saw a rise of 55.38%. Year-to-date, Petros Pharmaceuticals Inc shares have moved -25.62%, while the 5-day performance has seen it change 13.74%. Over the past 30 days, the shares of Petros Pharmaceuticals Inc (NASDAQ:PTPI) have changed -2.33%. Short interest in the company has seen 0.73 million shares shorted with days to cover at 0.55.
Petros Pharmaceuticals Inc (PTPI) estimates and forecasts
The company’s shares have lost -6.33% over the past 6 months.
PTPI Dividends
Petros Pharmaceuticals Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s Major holders
Insiders own 6.70% of the company shares, while shares held by institutions stand at 1.13% with a share float percentage of 1.22%. Investors are also buoyed by the number of investors in a company, with Petros Pharmaceuticals Inc having a total of 12.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund . As of Nov 30, 2024 , the former fund manager holds about 0.31% shares in the company for having 35.02 shares of worth $10262.0 while later fund manager owns 31.81 shares of worth $9320.0 as of Sep 30, 2024 , which makes it owner of about 0.28% of company’s outstanding stock.
